Literature DB >> 30076953

Solubility and dissolution rate enhancement of ibuprofen by co-milling with polymeric excipients.

Amjad Hussain1, Geoff Smith2, Karrar A Khan3, Nadeem Irfan Bukhari4, Nicholas I Pedge5, Irina Ermolina3.   

Abstract

The aim of this study was to enhance the kinetic solubility and dissolution rate of ibuprofen by co-milling with different excipients and to establish the underlying mechanism(s) for such enhancement. In the first-part, two excipients (HPMC and soluplus) were selected from seven, and the optimal ball-milling parameters of speed and time (18 Hz, 15 min) were determined based on solubility-enhancement and flow-ability criteria. In the second-part, co-milling of different weight-ratios of ibuprofen-to-excipient was carried out and solubility and dissolution rates were determined. Mechanisms of biopharmaceutical enhancement were studied by SEM, laser diffraction, DSC, and FTIR analysis of the co-mixtures. Ibuprofen solubility (0.09 mg/mL for un-milled) was increased by factors of 4-5 and 10-20 for HPMC and soluplus, respectively. The weakening of crystals, stabilization of the amorphous phase and an increase in solid-state hydrogen bonding are the likely mechanisms for this enhancement. Reductions in Q70% dissolution time were also observed, by a factor of 4 and 7 for ibuprofen:HMPC and ibuprofen:soluplus co-milled mixtures, respectively. Although, there were similar reductions in particle size, dispersibility and degree of amorphization in both mixtures, the higher dissolution rate for soluplus, over that for HPMC, must be due to the additional solubilization contribution to the kinetic solubility provided by soluplus.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Amorphous content; Ball milling; Dissolution rate; Particle size; Poor soluble drugs; Solubility enhancement

Mesh:

Substances:

Year:  2018        PMID: 30076953     DOI: 10.1016/j.ejps.2018.08.001

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  6 in total

1.  Red Fluorescence of Eu3+-Doped ZnAl-LDH Response to Intercalation and Release of Ibuprofen.

Authors:  Yufeng Chen; Xingxing Qiu; Chao Li; Yajiao Zhang; Yongxiu Li
Journal:  J Fluoresc       Date:  2022-01-06       Impact factor: 2.217

2.  Amorphization and modified release of ibuprofen by post-synthetic and solvent-free loading into tailored silica aerogels.

Authors:  Ajmal Zarinwall; Viktor Maurer; Jennifer Pierick; Victor Marcus Oldhues; Julian Cedric Porsiel; Jan Henrik Finke; Georg Garnweitner
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

3.  Applying Supercritical Fluid Technology to Prepare Ibuprofen Solid Dispersions with Improved Oral Bioavailability.

Authors:  Fei Han; Wei Zhang; Ying Wang; Ziyue Xi; Lu Chen; Sanming Li; Lu Xu
Journal:  Pharmaceutics       Date:  2019-02-03       Impact factor: 6.321

4.  Solubility Improvement of Progesterone from Solid Dispersions Prepared by Solvent Evaporation and Co-milling.

Authors:  Xing Chen; Ioannis Partheniadis; Ioannis Nikolakakis; Hisham Al-Obaidi
Journal:  Polymers (Basel)       Date:  2020-04-07       Impact factor: 4.329

5.  Optimization and Prediction of Ibuprofen Release from 3D DLP Printlets Using Artificial Neural Networks.

Authors:  Marijana Madzarevic; Djordje Medarevic; Aleksandra Vulovic; Tijana Sustersic; Jelena Djuris; Nenad Filipovic; Svetlana Ibric
Journal:  Pharmaceutics       Date:  2019-10-18       Impact factor: 6.321

6.  Solubility and Dissolution Enhancement of Dexibuprofen with Hydroxypropylbetacyclodextrin (HPβCD) and Poloxamers (188/407) Inclusion Complexes: Preparation and In Vitro Characterization.

Authors:  Rabia Munir; Abdul Hadi; Salah-Ud-Din Khan; Sajid Asghar; Muhammad Irfan; Ikram Ullah Khan; Misbah Hameed; Sana Inam; Nayyer Islam; Shahzadi Filza Hassan; Memoona Ishtiaq; Pervaiz Akhtar Shah; Muhammad Shahid Iqbal; Haroon Khalid Syed; Ahmed Khames; Mohammad A S Abourehab
Journal:  Polymers (Basel)       Date:  2022-01-31       Impact factor: 4.329

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.